Aligos Therapeutics, Inc. · NASDAQ:ALGS
Alyeska Investment Group, L.P. reported a 9.99% stake in Aligos Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed May 15, 2025
Alyeska Investment Group, L.P. reported a 9.99% stake in Aligos Therapeutics, Inc., 530,000 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 530,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Alyeska Investment Group, L.P. | 9.99% | 530,000 |
| Alyeska Fund GP, LLC | 9.99% | 530,000 |
| Anand Parekh | 9.99% | 530,000 |
Source
Related
- Aligos Therapeutics, Inc.
- Alyeska Investment Group, L.P.
- Aligos Therapeutics, Inc. shareholders
- Schedule 13D · Lawrence M. Blatt · Jun 24, 2026
- Schedule 13G/A · Woodline Partners LP · May 15, 2026
- Schedule 13G · Lawrence M. Blatt · May 15, 2026
- Schedule 13G/A · Woodline Partners LP · Feb 17, 2026
- Schedule 13G/A · Sio Capital Management, LLC · Feb 11, 2026